Recombinant human erythropoietin (rhEPO) alleviates early brain injury following subarachnoid hemorrhage in rats: Possible involvement of Nrf2-ARE pathway

Cytokine

Volumn 52, Issue 3, 2010, Pages 252-257

  Zhang, Jian ^a   Zhu, Yun ^a   Zhou, Dai ^a   Wang, Zhong ^a   Chen, Gang ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

Early brain injury; Nrf2; RhEPO; Subarachnoid hemorrhage

Indexed keywords

GLUTATHIONE TRANSFERASE A1; HEME OXYGENASE 1; RECOMBINANT ERYTHROPOIETIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); TRANSCRIPTION FACTOR NRF2; NFE2L2 PROTEIN, RAT; PRIMER DNA;

ADULT ANIMAL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT RESPONSIVE ELEMENT; APOPTOSIS; ARTICLE; BLOOD BRAIN BARRIER; BRAIN CORTEX; BRAIN EDEMA; BRAIN INJURY; CONTROLLED STUDY; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SUBARACHNOID HEMORRHAGE; ANIMAL; NICK END LABELING; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT; WESTERN BLOTTING;

RATTUS;

ANIMALS; BASE SEQUENCE; BLOOD-BRAIN BARRIER; BLOTTING, WESTERN; BRAIN INJURIES; DNA PRIMERS; ERYTHROPOIETIN, RECOMBINANT; IN SITU NICK-END LABELING; MALE; NF-E2-RELATED FACTOR 2; POLYMERASE CHAIN REACTION; RATS; RATS, SPRAGUE-DAWLEY; SUBARACHNOID HEMORRHAGE;

EID: 79953330040     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2010.08.011     Document Type: Article

References (20)

1. Cahill J., Calvert J.W., Zhang J.H. Mechanisms of early brain injury after subarachnoid hemorrhage. J Cereb Blood Flow Metab 2006, 26:1341-1353.
2. Grasso G., Sfacteria A. Erythropoietin and subarachnoid hemorrhage. J Neurosurg 2010, 112:699-700.
3. Tseng M.Y., Hutchinson P.J., Richards H.K., Czosnyka M., Pickard J.D., Erber W.N., et al. Acute systemic erythropoietin therapy to reduce delayed ischemic deficits following aneurysmal subarachnoid hemorrhage: a Phase II randomized, double-blind, placebo-controlled trial. J Neurosurg 2009, 111:171-180.
4. Chen G., Zhang S., Shi J., Ai J., Hang C. Effects of recombinant human erythropoietin (rhEPO) on JAK2/STAT3 pathway and endothelial apoptosis in the rabbit basilar artery after subarachnoid hemorrhage. Cytokine 2009, 45:162-168.
5. Springborg J.B., Møller C., Gideon P., Jørgensen O.S., Juhler M., Olsen N.V. Erythropoietin in patients with aneurysmal subarachnoid haemorrhage: a double blind randomised clinical trial. Acta Neurochir (Wien) 2007, 149:1089-1101.
6. Ostrowski R.P., Colohan A.R., Zhang J.H. Molecular mechanisms of early brain injury after subarachnoid hemorrhage. Neurol Res 2006, 28:399-414.
7. Cahill J., Zhang J.H. Subarachnoid hemorrhage: is it time for a new direction?. Stroke 2009, 40(3 Suppl.):S86-S87.
8. Ayer R.E., Zhang J.H. Oxidative stress in subarachnoid haemorrhage: significance in acute brain injury and vasospasm. Acta Neurochir Suppl 2008, 104:33-41.
9. Jin W., Wang H., Ji Y., Hu Q., Yan W., Chen G., et al. Increased intestinal inflammatory response and gut barrier dysfunction in Nrf2-deficient mice after traumatic brain injury. Cytokine 2008, 44:135-140.
10. Calkins M.J., Townsend J.A., Johnson D.A., Johnson J.A. Cystamine protects from 3-nitropropionic acid lesioning via induction of nf-e2 related factor 2 mediated transcription. Exp Neurol 2010, 224:307-317.
11. Genc S., Egrilmez M.Y., Genc K. Endothelial nitric oxide-mediated Nrf2 activation as a novel mechanism for vascular and neuroprotection by erythropoietin in experimental subarachnoid hemorrhage. Med Hypotheses 2006, 67:424.
12. Genc K., Egrilmez M.Y., Genc S. Erythropoietin induces nuclear translocation of Nrf2 and heme oxygenase-1 expression in SH-SY5Y cells. Cell Biochem Funct 2010, 28:197-201.
13. Wang Z., Chen G., Zhu W.W., Bian J.Y., Shen X.O., Zhou D. Influence of simvastatin on microthrombosis in the brain after subarachnoid hemorrhage in rats: a preliminary study. Ann Clin Lab Sci 2010, 40:32-42.
14. Grasso G., Buemi M., Alafaci C., Sfacteria A., Passalacqua M., Sturiale A., et al. Beneficial effects of systemic administration of recombinant human erythropoietin in rabbits subjected to subarachnoid hemorrhage. Proc Natl Acad Sci USA 2002, 99:5627-5631.
15. Chen G., Zhang S., Shi J., Ai J., Qi M., Hang C. Simvastatin reduces secondary brain injury caused by cortical contusion in rats: possible involvement of TLR4/NF-kappaB pathway. Exp Neurol 2009, 216:398-406.
16. Prunell G.F., Mathiesen T., Svendgaard N.A. A new experimental model in rats for study of the pathophysiology of subarachnoid hemorrhage. Neuroreport 2002, 13:2553-2556.
17. Prunell G.F., Svendgaard N.A., Alkass K., Mathiesen T. Inflammation in the brain after experimental subarachnoid hemorrhage. Neurosurgery 2005, 56:1082-1092.
18. Prunell G.F., Mathiesen T., Svendgaard N.A. Experimental subarachnoid hemorrhage: cerebral blood flow and brain metabolism during the acute phase in three different models in the rat. Neurosurgery 2004, 54:426-436.
19. Yan J., Chen C., Hu Q., Yang X., Lei J., Yang L., et al. The role of p53 in brain edema after 24h of experimental subarachnoid hemorrhage in a rat model. Exp Neurol 2008, 214:37-46.
20. Osburn W.O., Wakabayashi N., Misra V., Nilles T., Biswal S., Trush M.A., et al. Nrf2 regulates an adaptive response protecting against oxidative damage following diquat-mediated formation of superoxide anion. Arch Biochem Biophys 2006, 454:7-15.